Venkateswarlu Nelabhotla

Venkat brings a very rich and global experience of more than 25 years, successfully leading organizations in the biotech and cosmeceutics businesses. He held top management roles in biotech and pharmaceutical companies like ShanthaBiotechnics (A Sanofi Company) and Aurobindo Pharma, roles in which he immensely contributed to the Companies' all-round growth. He was instrumental in creating market focus and orchestrating vaccine portfolio strategy in Shantha Biotech, a biosimilar and vaccine company, which was eventually acquired by Sanofi for $800 million. He has been a part of significant revenue growth and value creation in Aurobindo Pharma in the global business segment of APIs and finished dosage form products in multiple therapy areas.

He has held CEO and President roles in Emami and Cavinkare, cosmeceutical and consumer product companies in India with global operations, creating value and growing them significantly with an all-rounded approach. During his time at Emami (a publicly listed company) as CEO, the company's market cap increased from $ 300 million to $ 1.2 billion. During the early part of his career, he created some very successful cosmeceutical brands in Cavinkare, and built the organization with a 10x revenue increase in 6 years' time.

He comes with core strengths in Strategy, Innovation, Technology, Commercialization, Organization building, Finance, M&A. Venkat has received his B.Tech in Mechanical Engineering and an MBA from Indian Institute of Management - Ahmedabad, India.